Advances in patent applications related to allergen immunotherapy

References

• Figueiredo CA, Amorim LD, Alcantara-Neves NM, et al. Environmental conditions, immunologic phenotypes, atopy, and asthma: new evidence of how the hygiene hypothesis operates in Latin America. J Allergy Clin Immunol. 2013;131:1064–1068, 1068.e1.
   PubMed Web of Science ®Google Scholar
• Keet CA, McCormack MC, Pollack CE, et al. Neighbourhood poverty, urban residence, race/ethnicity, and asthma: rethinking the inner-city asthma epidemic. J Allergy Clin Immunol. 2015;135:655–662.
   PubMed Web of Science ®Google Scholar
• WAO: WAO white book on allergy : update 2013. Milwaukee (WI): World Allergy Organisation; 2013.
   Google Scholar
• Brandao HV, Cruz CS, Guimaraes A, et al. Predictors of hospital admission due to asthma in children and adolescents enrolled in an asthma control program. J Bras Pneumol. 2010;36:700–706.
   PubMed Web of Science ®Google Scholar
• Ciriaco M, Ventrice P, Russo G, et al. Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother. 2013;4:S94–S98.
   PubMedGoogle Scholar
• Zöllner EW, Lombard C, Galal U, et al. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids: is the early-morning serum adrenocorticotropic hormone (ACTH) a useful screening test?. Pediatr Allergy Immunol. 2011;22:614–620.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Akdis M. Advances in allergen immunotherapy : aiming for complete tolerance to allergens. Sci Transl Med. 2015;7:1–6.
   Web of Science ®Google Scholar
• Doherty T, Group BD. 2 innate lymphoid cells : new players in human allergic diseases. J Investig Allergol Clin Immunol. 2015;25:1–11.
   PubMed Web of Science ®Google Scholar
• Zhu J. T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production [Internet]. Cytokine. 2015;75:14–24.
   PubMed Web of Science ®Google Scholar
• Naji N, Smith SG, Gauvreau GM, et al. T helper 17 cells and related cytokines after allergen inhalation challenge in allergic asthmatics. Int Arch Allergy Immunol. 2014;165:27–34.
   PubMed Web of Science ®Google Scholar
• Hammad H, Lambrecht BN. Barrier epithelial cells and the control of type 2 immunity. Immunity. 2015;43:29–40.
   PubMed Web of Science ®Google Scholar
• Worm M, Henz BM. Molecular regulation of human IgE synthesis. J Mol Med (Berl). 1997;75:440–447.
   PubMed Web of Science ®Google Scholar
• Casale TB, Stokes JR. Immunotherapy: what lies beyond. J Allergy Clin Immunol. 2014;133:612–619.
   PubMed Web of Science ®Google Scholar
• Gafvelin G, Parmley S, Neimert-Andersson T, et al. Hypoallergens for allergen-specific immunotherapy by directed molecular evolution of mite group 2 allergens. J Biol Chem. 2007;282:3778–3787.
   PubMed Web of Science ®Google Scholar
• Marogna M, Spadolini I, Massolo A, et al. Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study. J Allergy Clin Immunol. 2010;126:969–975.
   PubMed Web of Science ®Google Scholar
• Wallner M, Pichler U, Ferreira F. Recombinant allergens for pollen immunotherapy. Immunotherapy. 2013;5:1323–1338.
   PubMed Web of Science ®Google Scholar
• Yu S-J, Liao E-C, Tsai J-J. Effects of local nasal immunotherapy in allergic airway inflammation: using urea denatured dermatophagoides pteronyssinus. Hum Vaccin Immunother. 2015;11:915–921.
   PubMed Web of Science ®Google Scholar
• Mari A, Scala E. Allergenic extracts for specific immunotherapy : to mix or not to mix?. Int Arch Allergy Immunol. 2006;141:57–60.
   PubMed Web of Science ®Google Scholar
• Ferreira F, Wolf M, Wallner M, Molecular approach to allergy diagnosis and therapy. Yonsei Med J. 2014;55:839–852.
   PubMed Web of Science ®Google Scholar
• De Queirós MGJ, Oliveira Silva DA, Alves R, et al. Mite-specific immunotherapy using allergen and/or bacterial extracts in atopic patients in Brazil. J Investig Allergol Clin Immunol. 2008;18:84–92.
   PubMed Web of Science ®Google Scholar
• Brunetto B, Tinghino R, Braschi MC, et al. Characterisation and comparison of commercially available mite extracts for in vivo diagnosis. Allergy Eur J Allergy Clin Immunol. 2010;65:184–190.
   Web of Science ®Google Scholar
• Valenta R, Linhart B, Swoboda I, et al. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens. Allergy. 2011;66:775–783.
   PubMed Web of Science ®Google Scholar
• Cox L. Allergen immunotherapy and asthma: efficacy, safety, and other considerations. Allergy Asthma Proc. 2013;29:580–589.
   Web of Science ®Google Scholar
• Gangl K, Niederberger V, Valenta R. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis. Clin Exp Allergy. 2013;43:1202–1216.
   PubMed Web of Science ®Google Scholar
• Jutel M, Jaeger L, Suck R, et al. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol. 2005;116:608–613.
   PubMed Web of Science ®Google Scholar
• Vrtala S, Focke-Tejkl M, Swoboda I, et al. Strategies for converting allergens into hypoallergenic vaccine candidates. Methods. 2004;32:313–320.
   PubMed Web of Science ®Google Scholar
• Thalhamer T, Dobias H, Stepanoska T, et al. Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening. J Allergy Clin Immunol. 2010;125:926–934.
   PubMed Web of Science ®Google Scholar
• Chen K-W, Blatt K, Thomas WR, et al. Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy. J Allergy Clin Immunol. 2012;130:435–43.e4.
   PubMed Web of Science ®Google Scholar
• Egger M, Jürets A, Wallner M, et al. Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome. PLoS One. 2011;6:e17278.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Weber M, Blatt K, et al. Conversion of der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine. J Immunol. 2014;192:4867–4875.
   PubMed Web of Science ®Google Scholar
• Linhart B, Focke-Tejkl M, Weber M, et al. Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy. J Immunol. 2015;194:4008–4018.
   PubMed Web of Science ®Google Scholar
• Focke-Tejkl M, Valenta R. Safety of engineered allergen-specific immunotherapy vaccines. Curr Opin Allergy Clin Immunol. 2012;12:555–583.
   PubMed Web of Science ®Google Scholar
• Musse APS, Quintella CM, Recuperação avançada de petróleo. Cad Prospecção. 2009;290:12–22.
   Google Scholar
• Marques LS, Cordeiro de Oliveira OM, Quintella CM. Mapeamento tecnológico da utilização da glicerina coproduto da produção do biodiesel na remediação de áreas impactadas por atividades petrolíferas. Cadernos De Prospecção. 2015;8:301–310.
   Google Scholar
• El-qutob D, Mencia G, Fernandez-caldas E. Recent advances in immunotherapy for allergic diseases. Recent Pat Inflamm Allergy Drug Discov. 2014;8:24–35.
   PubMedGoogle Scholar
• Ben-Shoshan M, Soller L, Harrington DW, et al. Eczema in early childhood, sociodemographic factors and lifestyle habits are associated with food allergy: a nested case-control study. Int Arch Allergy Immunol. 2015;166:199–207.
   PubMed Web of Science ®Google Scholar
• Koplin JJ, Wake M, Dharmage SC, et al. Cohort profile of the healthnuts study: population prevalence and environmental/genetic predictors of food allergy. Int J Epidemiol. 2015;44:1–11.
   PubMed Web of Science ®Google Scholar
• Prescott S, Nowak-Węgrzyn A. Strategies to prevent or reduce allergic disease. Ann Nutr Metab. 2011;59(Suppl 1):28–42.
   PubMedGoogle Scholar
• Kusunoki T, Morimoto T, Nishikomori R, et al. Allergic status of schoolchildren with food allergy to eggs, milk or wheat in infancy. Pediatr Allergy Immunol. 2009;20:642–647.
   PubMed Web of Science ®Google Scholar
• Gupta RS, Springston EE, Warrier MR, et al. The prevalence, severity, and distribution of childhood food allergy in the United States. Paediatrics. 2011;128:e9–e17.
   PubMed Web of Science ®Google Scholar
• Canadian Biotechnology Advisory Committee: human genetic materials: making Canada’s intellectual property regime work for the health of canadians human genetic materials: regime work for the health of canadians report of the expert working party on human genetic materials. Ottawa: Intellectual Proper; 2005.
   Google Scholar
• Nicholas T. The origins of Japanese technological modernisation. Explor Econ Hist. 2011;48:272–291.
   Web of Science ®Google Scholar
• Ono S. Trilateral cooperation – mutual exploitation of search and examination results among patent offices with a view to establishing a system of rationalised work-sharing. In: Edward Elgar TT, editor. Patent law and theory. Camberley: Edward Elgar Pub; 2008. p. 271–280.
   Google Scholar
• Maloney J, Prenner BM, Bernstein DI, et al. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites. Ann Allergy Asthma Immunol. 2015;116:59–65.
   PubMed Web of Science ®Google Scholar
• Osborne R. Synthetic peptide allergy vaccine shows efficacy. Nat Publ Gr. 2013;31:371–372.
   Google Scholar
• Niederberger V, Marth K, Eckl-Dorna J, et al. Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients. J Allergy Clin Immunol. 2015;136:1101–1103.e8.
   PubMed Web of Science ®Google Scholar
• Wallner M, Bohle B, Hauser M, et al. Hypoallergenic molecules. 2009: WO2008EP05324.
   Google Scholar
• Spertini F, Perrin Y, Audran R, et al. Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides. J Allergy Clin Immunol. 2014;134:239–240.e13.
   PubMed Web of Science ®Google Scholar
• Llerna L, Caraballo L, Cantillo J, et al.. Fusion proteins representing different ns: proposal for a vaccine against allergy to mites. 2011: WO2014045084.
   Google Scholar
• Berman EP. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act. Soc Stud Sci. 2008;38:835–871.
   PubMed Web of Science ®Google Scholar
• Bermudez J, ’T Hoen E. The UNITAID patent pool initiative: bringing patents together for the common good. Open AIDS J. 2010;4:37–40.
   PubMedGoogle Scholar
• Germann PG, Schuhmacher A, Harrison J, et al. How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective. Hum Genomics. 2013;7:5.
   PubMed Web of Science ®Google Scholar
• Burks AW, Calderon MA, Casale T, et al. Update on allergy immunotherapy: American academy of allergy, asthma & immunology/european academy of allergy and clinical immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2013;131:1288–1296.e3.
   PubMed Web of Science ®Google Scholar
• Hafner RP, Laidler P, Larche M. Peptide for vaccine. 2014: WO2008GB02780.
   Google Scholar
• Li J, Wang H, Chen Y, et al. House dust mite sensitisation is the main risk factor for the increase in prevalence of wheeze in 13- To 14-year-old schoolchildren in Cuangzhou city, China. Clin Exp Allergy. 2013;43:1171–1179.
   PubMed Web of Science ®Google Scholar
• Hosseini S, Shokouhi Shoormasti R, Akramian R, et al. Skin prick test reactivity to common aero and food allergens among children with allergy children. Iran J Med Sci. 2014;39:29–35.
   PubMedGoogle Scholar
• Anagnostou K, Clark A. The management of peanut allergy. Arch Dis Child. 2014;100:68–72.
   PubMed Web of Science ®Google Scholar
• Choi Y, Ju S, Chang H. Food allergy knowledge, perception of food allergy labeling, and level of dietary practice: A comparison between children with and without food allergy experience. Nutr Res Pract. 2015;9:92.
   PubMed Web of Science ®Google Scholar
• Zhang X, Morrison-Carpenter T, Holt JB, et al. Trends in adult current asthma prevalence and contributing risk factors in the United States by state: 2000–2009. BMC Public Health. 2013;13:1156.
   PubMed Web of Science ®Google Scholar
• Rpdc B, Fernandes MDFM, Baldaçara L, et al. Prevalence of allergen sensitization, most important allergens and factors associated with atopy in children. Sao Paulo Med J. 2013;131:301–308.
   PubMed Web of Science ®Google Scholar
• Adeloye D, Yee K, Rudan I. An estimate of asthma prevalence in Africa: a systematic analysis. Croat Med J. 2013;54:519–531.
   PubMed Web of Science ®Google Scholar
• Matthes A, Schmitz-Eiberger M. Apple (Malus domestica L. Borkh.) allergen Mal d 1: effect of cultivar, cultivation system, and storage conditions. J Agric Food Chem. 2009;57:10548–10553.
   PubMed Web of Science ®Google Scholar
• Wangorsch A, Jamin A, Foetisch K, et al. Identification of Sola l 4 as Bet v 1 homologous pathogenesis related-10 allergen in tomato fruits. Mol Nutr Food Res. 2015;59:582–592.
   PubMed Web of Science ®Google Scholar
• Arlian LG, Morgan MS, Vyszenski-Moher DL, et al. Cross-reactivity between storage and dust mites and between mites and shrimp. Exp Appl Acarol. 2009;47:159–172.
   PubMed Web of Science ®Google Scholar
• Becker S, Gröger M, Canis M, et al. Tropomyosin sensitization in house dust mite allergic patients. Eur Arch Oto-Rhino-Laryngology. 2012;269:1291–1296.
   PubMed Web of Science ®Google Scholar
• Petri A, Schulten V, Greenbaum JA, et al. Correction for Schulten et al., Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals. Proc Natl Acad Sci. 2013;110:5269–5269.
   Web of Science ®Google Scholar
• Smith M, Jäger S, Berger U, et al. Geographic and temporal variations in pollen exposure across Europe. Allergy Eur J Allergy Clin Immunol. 2014;69:913–923.
   Web of Science ®Google Scholar
• Valenta R, Focke-Tejkl M, Linhart B, et al. Vaccine carrier. 2015: WO2007AT00281.
   Google Scholar
• Winther L, Poulsen LK, Robin B, et al. Safety and tolerability of recombinant bet v 1 (rBet v 1) tablets in sublingual immunotherapy (SLIT). J Allergy Clin Immunol. 2009;123:830.
   Web of Science ®Google Scholar
• Gallego MT, Iraola V, Himly M, et al. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response. Int Arch Allergy Immunol. 2010;153:61–69.
   PubMed Web of Science ®Google Scholar
• López-matas MA, Gallego M, Iraola V, et al. Depigmented allergoids reveal new epitopes with capacity to induce IgG blocking antibodies. Biomed Res Int. 2013;2013:1–8.
   Web of Science ®Google Scholar
• Curin M, Weber M, Thalhamer T, et al. Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction. Clin Exp Allergy. 2014;44:882–894.
   PubMed Web of Science ®Google Scholar
• Valenta R, Campana R, Marth K, et al. Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. J Intern Med. 2012;272:144–157.
   PubMed Web of Science ®Google Scholar
• Chen K-W, Valenta R, Vrtala S. Hypoallergenic polypeptides for the treatment of house dust mite allergy. 2012: WO2011EP71377.
   Google Scholar
• Stemmer WP. DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc Natl Acad Sci U S A. 1994;91:10747–10751.
   PubMed Web of Science ®Google Scholar
• Kunkel TA. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985;82:488–492.
   PubMed Web of Science ®Google Scholar
• Ferreira F, Wallner M, Breiteneder H, et al. Genetic engineering of allergens for immunotherapy. Int Arch Allergy Immunol. 2002;128:171–178.
   PubMed Web of Science ®Google Scholar
• Westritschnig K, Focke M, Valent P, et al. Protein allergen derivatives. 2006: WO2005AT00486.
   Google Scholar
• Valenta R, Vrtala S, Vangelista L, et al. Non-anaphylactic forms of allergens and their use. 2006: WO1998SE01765.
   Google Scholar
• Wald M, Cromwell O, Nandy A, et al. Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity. 2014: WO2004EP04848.
   Google Scholar
• Vrtala S, Hirtenlehner K, Vangelista L, et al. Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments. Candidates for a novel form of specific immunotherapy. J Clin Invest. 1997;99:1673–1681.
   PubMed Web of Science ®Google Scholar
• Margit F, Dietrich K, Maria-Theresa K, et al. Process for the preparation of hypoallergenic mosaic antigens. 2004: WO2003EP14507.
   Google Scholar
• Mothes-Luksch N, Stumvoll S, Linhart B, et al. Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic protein. J Immunol. 2008;181:4864–4873.
   PubMed Web of Science ®Google Scholar
• Thalhamer J, Hartl A, Sippl M, et al. Hypoallergenic proteins. 2008: WO2008AT00049.
   Google Scholar
• Pichler U, Hauser M, Hofer H, et al. Allergen hybrids – next generation vaccines for fagales pollen immunotherapy. Clin Exp Allergy. 2014;44:438–449.
   PubMed Web of Science ®Google Scholar
• Burks AW, Wood RA, Jones SM, et al. Sublingual immunotherapy for peanut allergy: long-term follow-up of a randomized multicentre trial. J Allergy Clin Immunol. 2015;135:1–12.
   Web of Science ®Google Scholar
• Tao L, Shi B, Shi G, et al. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomised, double-blind, and placebo-controlled trials. Clin Respir J. 2014;8:192–205.
   PubMed Web of Science ®Google Scholar
• Durham SR, Emminger W, Kapp A, et al. SQ-standardised sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol. 2012;129:717–725.e5.
   PubMed Web of Science ®Google Scholar
• Demoly P, Calderon MA, Casale TB, et al. The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis. Clin Transl Allergy. 2015;5:1–10.
   PubMedGoogle Scholar
• Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: world allergy organisation position paper 2013 update. World Allergy Organ J. 2014;7:6.
   PubMedGoogle Scholar
• Oliveira-santos S, Motta-franco J, Barreto I, et al. Prevalence trends and associated factors in northeast Brazil. Allergol Immunopathol (Madr). 2015;43:429–435.
   PubMed Web of Science ®Google Scholar
• Ross B, ALK ABELLO AS. Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen. 2008: WO2008EP51138.
   Google Scholar
• Ortega JAA, Davalillo IIL De, Rodriguez MCA, et al. Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies. 2009: WO2009IB05114.
   Google Scholar
• Kettner A, Reymond C, S A A. Contiguous overlapping peptides for treatment of house dust mites allergy. 2014: WO2014IB01888.
   Google Scholar
• Cachat E, Newlands GFJ, Ekoja SE, et al. Attempts to immunise sheep against Haemonchus contortus using a cocktail of recombinant proteases derived from the protective antigen, H-gal-GP. Parasite Immunol. 2010;32:414–419.
   PubMed Web of Science ®Google Scholar
• van der Ree AM, Mutapi F. The helminth parasite proteome at the host–parasite interface – informing diagnosis and control. Exp Parasitol. 2015;157:48–58.
   PubMed Web of Science ®Google Scholar
• Oefner CM, Winkler A, Hess C, et al. Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J Allergy Clin Immunol. 2012;129:1647–1655.
   PubMed Web of Science ®Google Scholar
• Chabre H, Gouyon B, Huet A, et al. Molecular variability of group 1 and 5 grass pollen allergens between pooideae species: implications for immunotherapy. Clin Exp Allergy. 2010;40:505–519.
   PubMed Web of Science ®Google Scholar
• Yamamoto-Hino M, Muraoka M, Kondo S, et al. Dynamic regulation of innate immune responses in Drosophila by Senju-mediated glycosylation. Proc Natl Acad Sci. 2015;112:5809–5814.
   PubMed Web of Science ®Google Scholar
• Ramadan HAI, Saini KS, Baeshen NA, et al. Production of biopharmaceuticals in E. coli: current scenario and future perspectives. J Microbiol Biotechnol. 2015;25:953–962.
   PubMed Web of Science ®Google Scholar
• Roberts B, Antonopoulos A, Haslam SM, et al. Novel expression of Haemonchus contortus vaccine candidate aminopeptidase H11 using the free-living nematode Caenorhabditis elegans. Vet Res. 2013;44:1–15.
   PubMed Web of Science ®Google Scholar
• Li S, Goins B, Zhang L, et al. A novel multifunctional theranostic liposome drug delivery system: construction, characterisation, and multimodality MR, near-infrared fluorescent and nuclear imaging. Bioconjug Chem. 2012;29:1322–1332.
   Web of Science ®Google Scholar
• Zhao Y, Zhang S, Cui S, et al. Peptide-based cationic liposome-mediated gene delivery. Expert Opin Drug Deliv. 2012;9:127–139.
   PubMed Web of Science ®Google Scholar
• Mansour HM, Rhee YS, Wu X. Nanomedicine in pulmonary delivery. Int J Nanomedicine. 2009;4:299–319.
   PubMed Web of Science ®Google Scholar
• Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975–999.
   PubMed Web of Science ®Google Scholar